Loading
BL
Britannia Life Sciences Inc. Stock: price and insider trades · Canada
Britannia Life Sciences Inc.: what insiders have been doing
This page follows insider dealings at Britannia Life Sciences Inc. as filed with SEDI. In the past year (23 October 2025 to 23 October 2026), 3 filings came from 1 insider.
No insider sold shares on the market over the period. Instead, the filings list 1 purchase totalling €1,205, made by 1 insider. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The largest single trade was a purchase of €1,205 by Shippen, Peter James, published on 11 March 2026. Among those who bought: 1 senior executive.
The last purchase on record was published on 11 March 2026, which is 227 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 5 days. The shorter that gap, the sooner other investors can see what insiders have done.
For context, the typical company on the same exchange (median of 2,640 companies) published 13 filings over the same period, against 3 filings here. Since 2024, the database holds 1 purchase and no sales by insiders of the company.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
4
Thresholds
n/a
Buy Volume
€1,205
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySalePeter James Shippen1 buy
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
CA$0.06
Last declaration on 21 July 2026
Declarations4 total
3,500,000 shares@ CA$0.062.78% mcap100.0% of flowCommon SharesTSXSEDI:4754739
3,500,000 sharesWarrantsTSXSEDI:4754738
20,000 shares@ CA$0.0950.9% of flowCommon SharesTSXSEDI:4678350
Canonical exit: 9 Jun 2026 (T+90)
3,499,860 shares@ CA$0.06100.0% of flowWarrantsTSXSEDI:4352453
4 of 4 declarations
About Britannia Life Sciences Inc.
Britannia Life Sciences Inc. is a company listed on the Toronto Stock Exchange, specializing in the life sciences sector. It focuses on developing innovative solutions to enhance health and well-being.
